Clinical trial
Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on…
NCT00444106 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00444106 |
|---|---|
| Title | Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function |
| Official title | An Open-label, Randomized, Single-center, Parallel Group Study of the Effects of Artemether-lumefantrine (Coartem®) Atovaquone-proguanil (Malarone®) and Artesunate-mefloquine on Auditory Function Following the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Patients 12 Years of Age… |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria, Falciparum |
| Intervention type | Drug |
| Interventions | Artesunate-mefloquine, Atovaquone-proguanil, Artemether-lumefantrine |
| Enrollment | 265 |
| Start date | May 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Mar 7, 2007 |
| Last update posted | Apr 5, 2011 |
| Countries | Colombia |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: